Werewolf Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.048; its P/E ratio is -5.60; Werewolf Therapeutics is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 5.90M	-	$ 400.00K	$ 350.00K	$ 4.97M
Gross Profit	-	-	$ 400.00K	$ 350.00K	-
EBIT	$ -8.29M	$ -5.10M	$ -13.29M	$ -13.46M	$ -12.54M
EBITDA	$ -7.30M	-	$ -12.47M	$ -12.72M	$ -12.13M
Net Income Common Stockholders	$ -8.29M	$ -5.10M	$ -11.95M	$ 29.95M	$ -11.94M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 130.06M	$ 137.45M	$ 147.87M	$ 129.31M	$ 140.45M
Total Assets	$ 176.39M	$ 185.24M	$ 195.07M	$ 160.25M	$ 172.42M
Total Debt	$ 52.19M	$ 52.82M	$ 53.25M	$ 14.68M	$ 15.16M
Net Debt	$ -77.87M	$ -84.64M	$ -94.62M	$ -114.63M	$ -125.29M
Total Liabilities	$ 63.94M	$ 66.65M	$ 74.00M	$ 37.91M	$ 41.48M
Stockholders Equity	$ 112.44M	$ 118.60M	$ 121.07M	$ 122.34M	$ 130.95M
Cash Flow	-
Free Cash Flow	$ -7.43M	-	$ -10.07M	$ -12.39M	$ -16.43M
Operating Cash Flow	$ -7.21M	-	$ -9.90M	$ -11.87M	$ -14.47M
Investing Cash Flow	$ -221.00K	-	$ -168.00K	$ -518.00K	$ -1.95M
Financing Cash Flow	$ 41.00K	-	$ 48.62M	$ 1.26M	$ 11.08M

Currency in USD

Werewolf Therapeutics Earnings and Revenue History

Income Statement >

Werewolf Therapeutics Debt to Assets

Balance Sheet >

Werewolf Therapeutics Cash Flow

Cash Flow >

Werewolf Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing